- Home
- WVE vs BRKL Comparison
WVE vs BRKL Comparison
Compare WVE & BRKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WVE
- BRKL
- Stock Information
- Founded
- WVE 2012
- BRKL 1871
- Country
- WVE Singapore
- BRKL United States
- Employees
- WVE N/A
- BRKL N/A
- Industry
- WVE Biotechnology: Pharmaceutical Preparations
- BRKL Savings Institutions
- Sector
- WVE Health Care
- BRKL Finance
- Exchange
- WVE Nasdaq
- BRKL Nasdaq
- Market Cap
- WVE 915.6M
- BRKL 944.5M
- IPO Year
- WVE 2015
- BRKL 1998
- Fundamental
- Price
- WVE $6.95
- BRKL $11.30
- Analyst Decision
- WVE Strong Buy
- BRKL Buy
- Analyst Count
- WVE 13
- BRKL 2
- Target Price
- WVE $20.15
- BRKL $15.25
- AVG Volume (30 Days)
- WVE 1.0M
- BRKL 613.8K
- Earning Date
- WVE 08-07-2025
- BRKL 07-23-2025
- Dividend Yield
- WVE N/A
- BRKL 4.78%
- EPS Growth
- WVE N/A
- BRKL N/A
- EPS
- WVE N/A
- BRKL 0.82
- Revenue
- WVE $104,939,000.00
- BRKL $338,567,000.00
- Revenue This Year
- WVE N/A
- BRKL $53.95
- Revenue Next Year
- WVE $1.94
- BRKL $68.33
- P/E Ratio
- WVE N/A
- BRKL $13.78
- Revenue Growth
- WVE N/A
- BRKL N/A
- 52 Week Low
- WVE $5.04
- BRKL $8.35
- 52 Week High
- WVE $16.74
- BRKL $13.15
- Technical
- Relative Strength Index (RSI)
- WVE 53.71
- BRKL 68.22
- Support Level
- WVE $6.25
- BRKL $10.52
- Resistance Level
- WVE $7.10
- BRKL $10.61
- Average True Range (ATR)
- WVE 0.39
- BRKL 0.24
- MACD
- WVE -0.01
- BRKL 0.11
- Stochastic Oscillator
- WVE 75.27
- BRKL 94.29
About WVE Wave Life Sciences Ltd.
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
About BRKL Brookline Bancorp Inc.
Brookline Bancorp Inc operates as a multi-bank holding company. It offers commercial, business, and retail banking services, including a full complement of cash management products, online banking services, and consumer and residential loans.